JT Aesthetics Limited 12201267 false 2024-10-01 2025-09-30 2025-09-30 The principal activity of the company is that of the provision of medical treatments. Digita Accounts Production Advanced 6.30.9574.0 true true 12201267 2024-10-01 2025-09-30 12201267 2025-09-30 12201267 bus:OrdinaryShareClass1 2025-09-30 12201267 core:HirePurchaseContracts core:CurrentFinancialInstruments 2025-09-30 12201267 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2025-09-30 12201267 core:CurrentFinancialInstruments 2025-09-30 12201267 core:CurrentFinancialInstruments core:WithinOneYear 2025-09-30 12201267 core:Non-currentFinancialInstruments 2025-09-30 12201267 core:Non-currentFinancialInstruments core:AfterOneYear 2025-09-30 12201267 core:FurnitureFittings 2025-09-30 12201267 core:LandBuildings core:LongLeaseholdAssets 2025-09-30 12201267 core:MotorVehicles 2025-09-30 12201267 core:OfficeEquipment 2025-09-30 12201267 core:PlantMachinery 2025-09-30 12201267 bus:SmallEntities 2024-10-01 2025-09-30 12201267 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 12201267 bus:FilletedAccounts 2024-10-01 2025-09-30 12201267 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 12201267 bus:RegisteredOffice 2024-10-01 2025-09-30 12201267 bus:Director1 2024-10-01 2025-09-30 12201267 bus:Director2 2024-10-01 2025-09-30 12201267 bus:OrdinaryShareClass1 2024-10-01 2025-09-30 12201267 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 12201267 core:FurnitureFittings 2024-10-01 2025-09-30 12201267 core:LandBuildings core:LongLeaseholdAssets 2024-10-01 2025-09-30 12201267 core:LeaseholdImprovements 2024-10-01 2025-09-30 12201267 core:MotorVehicles 2024-10-01 2025-09-30 12201267 core:OfficeEquipment 2024-10-01 2025-09-30 12201267 core:PlantMachinery 2024-10-01 2025-09-30 12201267 countries:AllCountries 2024-10-01 2025-09-30 12201267 2024-09-30 12201267 core:FurnitureFittings 2024-09-30 12201267 core:LandBuildings core:LongLeaseholdAssets 2024-09-30 12201267 core:MotorVehicles 2024-09-30 12201267 core:OfficeEquipment 2024-09-30 12201267 core:PlantMachinery 2024-09-30 12201267 2023-10-01 2024-09-30 12201267 2024-09-30 12201267 bus:OrdinaryShareClass1 2024-09-30 12201267 core:HirePurchaseContracts core:CurrentFinancialInstruments 2024-09-30 12201267 core:HirePurchaseContracts core:Non-currentFinancialInstruments 2024-09-30 12201267 core:CurrentFinancialInstruments 2024-09-30 12201267 core:CurrentFinancialInstruments core:WithinOneYear 2024-09-30 12201267 core:Non-currentFinancialInstruments 2024-09-30 12201267 core:Non-currentFinancialInstruments core:AfterOneYear 2024-09-30 12201267 core:FurnitureFittings 2024-09-30 12201267 core:LandBuildings core:LongLeaseholdAssets 2024-09-30 12201267 core:MotorVehicles 2024-09-30 12201267 core:OfficeEquipment 2024-09-30 12201267 core:PlantMachinery 2024-09-30 12201267 bus:OrdinaryShareClass1 2023-10-01 2024-09-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12201267

JT Aesthetics Limited

trading as Vizage

Unaudited Filleted Financial Statements

for the Year Ended 30 September 2025

 

JT Aesthetics Limited

trading as Vizage

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 11

 

JT Aesthetics Limited

trading as Vizage

Company Information

Directors

Dr Jasmin Magdy Mohamed Taher

Mr Ahmed Salaheldin

Registered office

Vizage
The Courtyard Fulham Palace
Bishops Avenue
Fulham
London
SW6 6EA

Accountants

Thorntons Accounting Limited
Chartered Certified Accountants
176-178 Pontefract Road
Cudworth
Barnsley
South Yorkshire
S72 8BE

 

JT Aesthetics Limited

trading as Vizage

(Registration number: 12201267)
Balance Sheet as at 30 September 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

4

606,917

488,003

Current assets

 

Stocks

5

30,000

30,000

Debtors

6

17,837

-

Cash at bank and in hand

 

16,531

117,069

 

64,368

147,069

Creditors: Amounts falling due within one year

7

(437,511)

(406,603)

Net current liabilities

 

(373,143)

(259,534)

Total assets less current liabilities

 

233,774

228,469

Creditors: Amounts falling due after more than one year

7

(53,974)

(84,026)

Net assets

 

179,800

144,443

Capital and reserves

 

Called up share capital

8

100

100

Retained earnings

179,700

144,343

Shareholders' funds

 

179,800

144,443

For the financial year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 May 2026 and signed on its behalf by:
 

 

JT Aesthetics Limited

trading as Vizage

(Registration number: 12201267)
Balance Sheet as at 30 September 2025

.........................................
Dr Jasmin Magdy Mohamed Taher
Director

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
Vizage
The Courtyard Fulham Palace
Bishops Avenue
Fulham
London
SW6 6EA

These financial statements were authorised for issue by the Board on 18 May 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Office equipment

10% straight line

Fixtures and Fittings

10% straight line

Plant and Machinery

10% straight line

Leasehold improvements

Over 6 years

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessee.

Assets held under finance leases are recognised at the lower of their fair value at inception of the lease and the present value of the minimum lease payments. These assets are depreciated on a straight-line basis over the shorter of the useful life of the asset and the lease term. The corresponding liability to the lessor is included in the balance sheet as a finance lease obligation.

Lease payments are apportioned between finance costs in the profit and loss account and reduction of the lease obligation so as to achieve a constant periodic rate of interest on the remaining balance of the liability.

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 6 (2024 - 3).

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

4

Tangible assets

Long leasehold land and buildings
£

Fixtures and fittings
£

Plant and machinery
£

Office equipment
£

Cost or valuation

At 1 October 2024

51,080

241,037

270,681

13,749

Additions

80,071

2,250

12,933

1,823

At 30 September 2025

131,151

243,287

283,614

15,572

Depreciation

At 1 October 2024

8,513

53,740

26,291

-

Charge for the year

17,409

25,886

28,361

-

At 30 September 2025

25,922

79,626

54,652

-

Carrying amount

At 30 September 2025

105,229

163,661

228,962

15,572

At 30 September 2024

42,567

187,297

244,390

13,749

Motor vehicles
 £

Total
£

Cost or valuation

At 1 October 2024

-

576,547

Additions

124,657

221,734

At 30 September 2025

124,657

798,281

Depreciation

At 1 October 2024

-

88,544

Charge for the year

31,164

102,820

At 30 September 2025

31,164

191,364

Carrying amount

At 30 September 2025

93,493

606,917

At 30 September 2024

-

488,003

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

Included within the net book value of land and buildings above is £105,229 (2024 - £42,567) in respect of long leasehold land and buildings.
 

5

Stocks

2025
£

2024
£

Other inventories

30,000

30,000

6

Debtors

2025
£

2024
£

Prepayments

17,837

-

17,837

-

 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

7

Creditors

Creditors: amounts falling due within one year

Note

2025
£

2024
£

Due within one year

 

Loans and borrowings

9

26,567

26,567

Trade creditors

 

15,723

19,893

Accruals and deferred income

 

5,148

2,044

Other creditors

 

390,073

358,099

 

437,511

406,603

Creditors: amounts falling due after more than one year

Note

2025
£

2024
£

Due after one year

 

Loans and borrowings

9

53,974

84,026

8

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary of £1 each

100

100

100

100

       
 

JT Aesthetics Limited

trading as Vizage

Notes to the Unaudited Financial Statements for the Year Ended 30 September 2025

9

Loans and borrowings

Non-current loans and borrowings

2025
£

2024
£

Bank borrowings

-

4,618

Hire purchase contracts

53,974

79,408

53,974

84,026

Current loans and borrowings

2025
£

2024
£

Hire purchase contracts

26,567

26,567

10

Dividends

Interim dividends paid

2025
£

2024
£

Interim dividend of £340.00 (2024 - £380.00) per each Ordinary

34,000

38,000

 

 

11

Related party transactions

Directors' remuneration

The directors' remuneration for the year was as follows:

2025
£

2024
£

Remuneration

12,570

11,992

Contributions paid to money purchase schemes

190

-

12,760

11,992